Quantitative in vivo receptor binding III: Tracer kinetic modeling of muscarinic cholinergic receptor binding.

door Frey, K A, Hichwa, R D, Ehrenkaufer, R L, Agranoff, B W
Gepubliceerd in 1985

Striatal [(11)C]dihydrotetrabenazine and [(11)C]methylphenidate binding in Tourette syndrome

door Albin, R L., Koeppe, R A., Wernette, K, Zhuang, W, Nichols, T, Kilbourn, M R., Frey, K A.
Gepubliceerd in 2009

Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease

door Ridder, A., Müller, M.L.T.M., Kotagal, V., Frey, K.A., Albin, R.L., Bohnen, N.I.
Gepubliceerd in Parkinsonism Relat Disord (2016)

History of falls in Parkinson disease is associated with reduced cholinergic activity

door Bohnen, N I., Müller, M L.T.M., Koeppe, R A., Studenski, S A., Kilbourn, M A., Frey, K A., Albin, R L.
Gepubliceerd in 2009

Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options

door Ludolph, A. C., Kassubek, J., Landwehrmeyer, B. G., Mandelkow, E., Mandelkow, E.-M., Burn, D. J., Caparros-Lefebvre, D., Frey, K. A., de Yebenes, J. G., Gasser, T., Heutink, P., Höglinger, G., Jamrozik, Z., Jellinger, K. A., Kazantsev, A., Kretzschmar, H., Lang, A. E., Litvan, I., Lucas, J. J., McGeer, P. L., Melquist, S., Oertel, W., Otto, M., Paviour, D., Reum, T., Saint-Raymond, A., Steele, J. C., Tolnay, M., Tumani, H., van Swieten, J. C., Vanier, M. T., Vonsattel, J.-P., Wagner, S., Wszolek, Z. K.
Gepubliceerd in 2009